Generations of Impact: How Tom Condon and His Daughter, Emily, Are Shaping the Future of Lymphoma Research For Tom Condon, a lymphoma diagnosis at age 31 was not just a life-altering moment — it was the beginning of a lifelong…
Lymphoma Research Foundation Awards 24 New Scientific Research Grants Nearly $4 Million Awarded to Advance Critical Cancer Research The Lymphoma Research Foundation — the nation’s largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma community…
Lymphoma Research Foundation Launches National Lymphoma Resource Center Newly Reimagined Lymphoma Resource Center Replaces and Expands upon their Lymphoma Helpline, Informed by the Foundation’s 30 Years of Experience Supporting Survivors The Lymphoma Research Foundation is proud to unveil its reimagined…
Lymphoma Research Foundation Supports the Comprehensive Cancer Survivorship Act May 14, 2026 – The Lymphoma Research Foundation commends the introduction of the Comprehensive Cancer Survivorship Act by Representatives Debbie Wasserman Schultz, Mark DeSaulnier, Brian Fitzpatrick, and Joe Wilson. This legislation…
The U.S. Food and Drug Administration (FDA) Approves Sonrotoclax for Mantle Cell Lymphoma May 13, 2026 – On May 13, 2026, the U.S. Food and Drug Administration (FDA) announced it has approved sonrotoclax (Beqalzi, BeOne Medicines USA, Inc.), a BCL-2…
The U.S. Food and Drug Administration (FDA) Approves Nivolumab for Hodgkin Lymphoma March 20, 2026- On March 20, 2026, the U.S. Food and Drug Administration (FDA) announced it has approved nivolumab (Opdivo, Bristol Myers Squibb Company) with doxorubicin, vinblastine, and…
The Lymphoma Research Foundation’s
Lymphoma Scientific Research Mentoring
Program (LSRMP) is a first-of-its-kind education and mentoring program for junior scientists
who wish to focus on lymphoma and CLL
research, whether in the lab or in the clinic.
Updates from the 2025 American Society of Hematology Annual Meeting The Lymphoma Research Foundation returned to the American Society of Hematology (ASH) Annual Meeting and Exposition, with 276 Foundation-affiliated scientists, including past and present members of the Foundation’s world-leading Scientific…
Where Are They Now? Sanket Shah, PhD Sanket Shah, PhD, is currently a postdoctoral fellow at Weill Cornell Medicine. When did you become interested in the study of medicine? In lymphoma specifically? My interest in science started early. My father…
Patient Perspectives: Access to CAR T-Cell Therapy One of the most revolutionary breakthroughs in cancer care comes from within a patient’s own cells: chimeric antigen receptor (CAR) T-cell therapy, which harnesses the powers of the body’s immune system to hone…
